Top-News

Sophiris Bio News

Keine aktuellen Kursdaten verfügbar
WKN: A1W39X
ISIN: CA83578Q2099
US-Symbol: SPHS
Typ: Aktie

Sophiris Bio News

18.05.20 - PR Newswire
Sophiris Bio To Shut Down Operations
Sophiris Bio To Shut Down Operations PR Newswire
30.08.19 - PR Newswire
Sophiris Bio to Present at the H.C. Wainwright 21st Annual Global Investment Conference
Sophiris Bio to Present at the H.C. Wainwright 21st Annual Global Investment Conference PR Newswire
30.08.19 - PR Newswire
Sophiris Bio Announces Completion of $4.0 Million Registered Direct Offering
Sophiris Bio Announces Completion of $4.0 Million Registered Direct Offering PR Newswire
09.08.19 - PR Newswire
Sophiris Bio Reports Second Quarter 2019 Financial Results and Recent Corporate Highlights
Sophiris Bio Reports Second Quarter 2019 Financial Results and Recent Corporate Highlights PR Newswire
19.06.19 - PR Newswire
Sophiris Bio Receives Positive Feedback from European Medicines Agency Regarding Phase 3 Localized Prostate Cancer Clinical Trial Design
Sophiris Bio Receives Positive Feedback from European Medicines Agency Regarding Phase 3 Localized Prostate Cancer Clinical Trial Design Conference call scheduled for today ...
09.05.19 - PR Newswire
Sophiris Bio Reports First Quarter 2019 Financial Results
Sophiris Bio Reports First Quarter 2019 Financial Results PR Newswire
02.04.19 - PR Newswire
Sophiris Bio to Present at Two Upcoming Investor Conferences
Sophiris Bio to Present at Two Upcoming Investor Conferences PR Newswire
13.03.19 - PR Newswire
Sophiris Bio Reports Fourth Quarter 2018 and Year-end Financial Results and Recent Corporate Highlights
Sophiris Bio Reports Fourth Quarter 2018 and Year-end Financial Results and Recent Corporate Highlights PR Newswire
17.12.18 - PR Newswire
Sophiris Bio Provides Updates on Phase 2b Localized Prostate Cancer Trial
Sophiris Bio Provides Updates on Phase 2b Localized Prostate Cancer Trial - Reiterates plans to move to Phase 3 with single administration of topsalysin PR Newswire
15.11.18 - PR Newswire
Sophiris Bio to Present at the Piper Jaffray Healthcare Conference
Sophiris Bio to Present at the Piper Jaffray Healthcare Conference PR Newswire
13.11.18 - PR Newswire
Sophiris Bio Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights
Sophiris Bio Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights PR Newswire
25.09.18 - PR Newswire
Sophiris Bio to Present at the Cantor Global Healthcare Conference
Sophiris Bio to Present at the Cantor Global Healthcare Conference PR Newswire
14.09.18 - PR Newswire
Sophiris Bio Extends the Interest Only Period under its Loan and Security Agreement
Sophiris Bio Extends the Interest Only Period under its Loan and Security Agreement PR Newswire
29.08.18 - PR Newswire
Sophiris Bio to Present at the H.C. Wainwright 20th Annual Global Investment Conference
Sophiris Bio to Present at the H.C. Wainwright 20th Annual Global Investment Conference PR Newswire
29.08.18 - PR Newswire
Sophiris Bio Updates on Phase 2b Localized Prostate Cancer Trial
Sophiris Bio Updates on Phase 2b Localized Prostate Cancer Trial Previously reported patient death determined unlikely to be related to topsalysin PR Newswire
14.08.18 - PR Newswire
Sophiris Bio Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights
Sophiris Bio Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights PR Newswire
25.06.18 - PR Newswire
Sophiris Bio Reports Top-Line Interim Safety and Biopsy Findings For its Phase 2b Clinical Trial of Topsalysin in Localized Prostate Cancer
Sophiris Bio Reports Top-Line Interim Safety and Biopsy Findings For its Phase 2b Clinical Trial of Topsalysin in Localized Prostate Cancer PR Newswire
14.05.18 - PR Newswire
Sophiris Bio Reports First Quarter 2018 Financial Results and Key Corporate Highlights
Sophiris Bio Reports First Quarter 2018 Financial Results and Key Corporate Highlights PR Newswire
21.03.18 - PR Newswire
Sophiris Bio Reports Fourth Quarter and Full Year 2017 Financial Results and Key Corporate Highlights
Sophiris Bio Reports Fourth Quarter and Full Year 2017 Financial Results and Key Corporate Highlights PR Newswire
15.03.18 - PR Newswire
Sophiris Bio to Present at 17th Annual Needham Healthcare Conference
Sophiris Bio to Present at 17th Annual Needham Healthcare Conference PR Newswire

Newssuche

Videos

newspaper
18.04.24
Technical Trading: Gold mit weiterem Potenzial
Gold Long Typ: Turbo Open End WKN: UH4MU6 Hebel: 4,67 Laufzeit: OpenEnd Einstieg: Market ... Mehr »